GCASX
Price
$51.39
Change
-$0.17 (-0.33%)
Updated
Jul 31 closing price
Net Assets
1.86B
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

GCASX vs VSMAX

GCASX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
GCASX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCASX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. GCASX (1.86B). VSMAX pays higher dividends than GCASX: VSMAX (1.21) vs GCASX (0.23). GCASX was incepted earlier than VSMAX: GCASX (23 years) vs VSMAX (26 years). GCASX (1.38) is less costly to investors than VSMAX (0.05). VSMAX is a more actively managed with annual turnover of: 17.00 vs. GCASX (1.00). GCASX has a lower initial minimum investment than VSMAX: GCASX (1000) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. GCASX (16.61). VSMAX return over 5 years is better than : 35.11 vs. GCASX (2.60).
GCASXVSMAXGCASX / VSMAX
Total Expense Ratio1.380.052,760%
Annual Report Gross Expense Ratio1.380.052,760%
Fund Existence23 years26 years-
Gain YTD13.94714.58896%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B189B1%
Annual Yield % from dividends0.231.2119%
Returns for 1 year16.6122.5874%
Returns for 3 years17.3643.4240%
Returns for 5 years2.6035.117%
Returns for 10 years5.65155.964%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H